Joel Morganroth

Direktor/Vorstandsmitglied bei ACR Image Metrix

78 Jahre

Consumer Services

Commercial Services

Health Technology

Aktive Positionen von Joel Morganroth

Unternehmen	Position	Beginn	Ende
ACR Image Metrix	Direktor/Vorstandsmitglied	27.10.2011	-
Eleison Pharmaceuticals, Inc. Eleison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Eleison Pharmaceuticals, Inc. engages in the acquisition, development and commercialization of clinical stage drug candidates for orphan oncology indications. Its portfolio of drug candidates consists of glufosfamide, inhaled lipid-complexed cisplatin (ILC) and dibromodulcitol (DBD). The company was founded by Edwin J. Thomas on October 14, 2009 and is headquartered in Princeton, NJ.	Direktor/Vorstandsmitglied	01.01.2018	-

Unternehmen	Position	Beginn	Ende
Perelman School of Medicine	Corporate Officer/Principal	-	-
ERT Operating Co. ERT Operating Co. Miscellaneous Commercial ServicesCommercial Services ERT Operating Co. engages in the provision of centralized electrocardiographic services. It offers safety and efficacy endpoint collection, data integration and analytics, and real-world evidence. The company was founded in 1977 and is headquartered in Philadelphia, PA.	Direktor/Vorstandsmitglied	01.01.1997	-
	Vorstandsvorsitzender	01.01.2011	30.04.2011
	Vorsitzender	01.01.1999	01.04.2011
	Technik-/Wissenschafts-/F&E-Leiter	01.05.2011	-
	Präsident	01.01.2011	30.04.2011

University of Michigan

Doctorate Degree

International

Vereinigte Staaten

Operativ

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Private Unternehmen	3
ERT Operating Co. ERT Operating Co. Miscellaneous Commercial ServicesCommercial Services ERT Operating Co. engages in the provision of centralized electrocardiographic services. It offers safety and efficacy endpoint collection, data integration and analytics, and real-world evidence. The company was founded in 1977 and is headquartered in Philadelphia, PA.	Commercial Services
ACR Image Metrix
Eleison Pharmaceuticals, Inc. Eleison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Eleison Pharmaceuticals, Inc. engages in the acquisition, development and commercialization of clinical stage drug candidates for orphan oncology indications. Its portfolio of drug candidates consists of glufosfamide, inhaled lipid-complexed cisplatin (ILC) and dibromodulcitol (DBD). The company was founded by Edwin J. Thomas on October 14, 2009 and is headquartered in Princeton, NJ.	Health Technology